Cultivates cannabis in British Columbia, Canada. Processes raw cannabis into various consumer products. Now — the numbers.
This is an established company with proven profits.
Average growth of 43% a year over the last 4 years. Red columns mark years that ended in a loss.
The gap is $5.1M. In times of high interest rates, a gap like that can squeeze a company.
The market pays 6.2× for every dollar of annual profit — cheap, which is either an opportunity or a warning.
No analyst target is on record for this company.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
An investor who bought at the very peak is down 94% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Over the last 4 years, sales grew about 43% a year on average.
The stock sits at $0.02. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.